Gujarat Petrosynthese Ltd
Incorporated in 1996, Gujarat Petrosynthese Ltd manufactures and deals in plastic polymers and blends[1]
- Market Cap ₹ 35.2 Cr.
- Current Price ₹ 59.0
- High / Low ₹ 81.5 / 51.5
- Stock P/E 14.6
- Book Value ₹ 85.2
- Dividend Yield 0.00 %
- ROCE 4.45 %
- ROE 2.93 %
- Face Value ₹ 10.0
Pros
- Company is almost debt free.
- Stock is trading at 0.69 times its book value
- Company is expected to give good quarter
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- The company has delivered a poor sales growth of -3.49% over past five years.
- Company has a low return on equity of 3.15% over last 3 years.
- Earnings include an other income of Rs.3.18 Cr.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Commodities Chemicals Chemicals & Petrochemicals Petrochemicals
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 8.99 | 8.78 | 11.15 | 17.68 | 18.89 | 22.07 | 20.21 | 19.34 | 30.02 | 19.55 | 13.85 | 16.92 | 21.21 | |
| 10.92 | 10.38 | 12.55 | 19.93 | 20.68 | 23.51 | 21.27 | 20.41 | 29.23 | 19.73 | 15.21 | 17.58 | 21.02 | |
| Operating Profit | -1.93 | -1.60 | -1.40 | -2.25 | -1.79 | -1.44 | -1.06 | -1.07 | 0.79 | -0.18 | -1.36 | -0.66 | 0.19 |
| OPM % | -21.47% | -18.22% | -12.56% | -12.73% | -9.48% | -6.52% | -5.24% | -5.53% | 2.63% | -0.92% | -9.82% | -3.90% | 0.90% |
| 1.46 | 1.66 | 1.81 | 3.00 | 2.08 | 0.30 | 2.77 | 6.21 | 1.88 | 2.41 | 2.94 | 3.22 | 3.18 | |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.03 | 0.00 | 0.00 | 0.01 | 0.01 | 0.02 | 0.01 | 0.00 |
| Depreciation | 0.39 | 0.50 | 0.32 | 0.27 | 0.23 | 0.23 | 0.25 | 0.18 | 0.22 | 0.25 | 0.27 | 0.34 | 0.33 |
| Profit before tax | -0.86 | -0.44 | 0.09 | 0.48 | 0.05 | -1.40 | 1.46 | 4.96 | 2.44 | 1.97 | 1.29 | 2.21 | 3.04 |
| Tax % | -46.51% | 9.09% | 444.44% | 6.25% | -1,140.00% | -22.14% | -2.05% | -1.01% | 20.49% | 29.44% | -28.68% | 33.94% | |
| -0.46 | -0.48 | -0.31 | 0.44 | 0.62 | -1.09 | 1.49 | 5.01 | 1.94 | 1.39 | 1.66 | 1.46 | 2.42 | |
| EPS in Rs | -0.81 | -0.80 | -0.52 | 0.74 | 1.04 | -1.83 | 2.50 | 8.39 | 3.25 | 2.33 | 2.78 | 2.45 | 4.06 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 7% |
| 5 Years: | -3% |
| 3 Years: | -17% |
| TTM: | 37% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 13% |
| 5 Years: | 30% |
| 3 Years: | -9% |
| TTM: | 120% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 14% |
| 5 Years: | 15% |
| 3 Years: | 22% |
| 1 Year: | 3% |
| Return on Equity | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 3% |
| 3 Years: | 3% |
| Last Year: | 3% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 5.64 | 5.97 | 5.97 | 5.97 | 5.97 | 5.97 | 5.97 | 5.97 | 5.97 | 5.97 | 5.97 | 5.97 | 5.97 |
| Reserves | 13.37 | 13.03 | 14.65 | 15.10 | 15.72 | 14.63 | 16.12 | 21.13 | 39.45 | 40.83 | 42.49 | 43.95 | 44.87 |
| 0.00 | 0.00 | 0.25 | 0.27 | 0.64 | 0.00 | 0.00 | 0.00 | 0.08 | 0.03 | 0.12 | 0.00 | 0.15 | |
| 2.86 | 1.99 | 2.55 | 2.19 | 1.58 | 2.07 | 1.37 | 1.83 | 2.67 | 3.08 | 2.14 | 3.42 | 3.12 | |
| Total Liabilities | 21.87 | 20.99 | 23.42 | 23.53 | 23.91 | 22.67 | 23.46 | 28.93 | 48.17 | 49.91 | 50.72 | 53.34 | 54.11 |
| 5.24 | 4.30 | 4.05 | 4.05 | 3.77 | 3.80 | 2.59 | 2.85 | 2.11 | 2.05 | 2.98 | 2.98 | 3.39 | |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.21 |
| Investments | 6.27 | 6.12 | 9.92 | 10.23 | 10.11 | 10.31 | 9.64 | 15.25 | 22.74 | 22.62 | 24.79 | 25.04 | 25.14 |
| 10.36 | 10.57 | 9.45 | 9.25 | 10.03 | 8.56 | 11.23 | 10.83 | 23.32 | 25.24 | 22.95 | 25.32 | 25.37 | |
| Total Assets | 21.87 | 20.99 | 23.42 | 23.53 | 23.91 | 22.67 | 23.46 | 28.93 | 48.17 | 49.91 | 50.72 | 53.34 | 54.11 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -1.54 | -1.63 | 2.67 | -2.06 | -1.18 | 0.15 | 1.43 | 4.20 | -1.86 | -2.79 | 1.18 | -3.00 | |
| -0.32 | 0.80 | -4.05 | 2.12 | 2.14 | -0.36 | 3.25 | -3.37 | 2.06 | 2.36 | -0.31 | 2.53 | |
| 1.76 | 0.85 | 1.94 | -0.07 | -0.07 | -0.66 | 0.00 | 0.00 | -0.05 | -0.06 | -0.07 | -0.06 | |
| Net Cash Flow | -0.10 | 0.02 | 0.56 | -0.01 | 0.88 | -0.87 | 4.68 | 0.83 | 0.15 | -0.49 | 0.80 | -0.53 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 75.52 | 84.39 | 66.13 | 44.80 | 31.30 | 37.87 | 32.51 | 45.29 | 44.26 | 98.95 | 56.13 | 73.56 |
| Inventory Days | 18.73 | 16.76 | 22.68 | 13.81 | 13.46 | 10.28 | 18.99 | 15.76 | 14.76 | 19.56 | 35.99 | 23.11 |
| Days Payable | 58.72 | 73.31 | 64.61 | 31.46 | 28.57 | 32.27 | 23.23 | 34.26 | 25.76 | 40.83 | 50.17 | 56.29 |
| Cash Conversion Cycle | 35.52 | 27.83 | 24.19 | 27.15 | 16.19 | 15.89 | 28.26 | 26.79 | 33.26 | 77.68 | 41.96 | 40.38 |
| Working Capital Days | 285.42 | 335.90 | 195.76 | 45.42 | 25.31 | 70.45 | 36.30 | 37.56 | 65.17 | 408.31 | 152.59 | 152.51 |
| ROCE % | -6.82% | -5.21% | -7.02% | -11.04% | -8.88% | -6.38% | -4.03% | -2.56% | 6.67% | 4.35% | 2.73% | 4.45% |
Insights
In beta| Mar 2016 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Sales Volume MT |
|
||||||||
| Employee Strength (Permanent) Number |
|||||||||
| New Customers Developed Number |
|||||||||
| New Products Developed Number |
|||||||||
| Target Annual Sales Capacity MT |
|||||||||
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
7 Feb - Copy of newspaper publications of the Unaudited Financial Results of the Company for the quarter and nine months ended December 31, 2025, approved at the …
-
Announcement under Regulation 30 (LODR)-Change in Management
6 Feb - Approved unaudited Q3/9M FY26 results (9M PBT 24,334 '000) and appointed Phiroz Munshi Chairman Feb 6, 2026.
- Financial Results For For The Quarter And Nine Months Ended December 31, 2025. 6 Feb
-
Board Meeting Outcome for Outcome Of The Board Meeting Of The Company Held Today I.E. February 6, 2026
6 Feb - Board approved Q3/9M results to Dec 31, 2025 and appointed Phiroz Munshi Chairman effective Feb 6, 2026.
-
Board Meeting Intimation for Board Meeting Intimation For Considering And Approval Of Unaudited Financial Results Along With The Limited Review Report.
3 Feb - Board meeting Feb 6, 2026 to consider unaudited Q3/9M results (Dec 31, 2025); trading window closed till Feb 11.
Annual reports
-
Financial Year 2025
from bse
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
Business Overview:[1][2]
GPSL is an ISO 9001:2015 and ISO 1400:2015 certified company which is engaged in the manufacture of polymer alloys and blends. It is one of the major sources for polymer compounding, coloring, alloying and blending of engineering plastics in South India, and has developed 17 new customers and 78 new products. In FY25, the company has started providing products for e-vehicles and medical equipment. The company is also developing import substitution and specialty products